Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | BRD4 | O60885 | 2/20 | 0.46 |
| ▸ | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | P62805 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TNF | P01375 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PDE6D | O43924 | 1/20 | 0.41 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24716371 | 0.85 | KDM4E (0.50) | KDM4ENPSR1TSHRBRD4H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | |
| SCHEMBL1350501 | 0.84 | TSHR (0.49) | KDM4ENPSR1TSHRBRD4H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | |
| SCHEMBL11151151 | 0.79 | ALDH1A1 (0.59) | KDM4ENPSR1TSHRBRD4H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | |
| SCHEMBL27398337 | 0.77 | KDM4E (0.56) | KDM4ENPSR1TSHRBRD4H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | |
| Hydrochloric Acid SCHEMBL27634345 | 0.77 | ALDH1A1 (0.58) | KDM4ENPSR1TSHRBRD4H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | |
| SCHEMBL18152765 | 0.76 | KDM4E (0.59) | KDM4ENPSR1TSHRBRD4H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | |
| SCHEMBL10040282 | 0.75 | MEN1 (0.67) | NPSR1TSHRGAATNFALDH1A1 | |
| Hydrochloric Acid SCHEMBL10837623 | 0.73 | MEN1 (0.55) | KDM4ENPSR1TSHRBRD4H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | |
| SCHEMBL10836880 | 0.73 | TSHR (0.51) | KDM4ENPSR1TSHRBRD4H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | |
| SCHEMBL18152842 | 0.73 | CFTR (0.47) | KDM4ENPSR1TSHRGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606666-B2 | Imidazoles and imidazolium cations with exceptional alkaline stability | CORNELL UNIVERSITY (US) | 2026-04-21 | — | — | US | disclosed |
| EP-4108691-A1 | IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | Cornell University (US) | 2022-12-28 | — | — | EP | disclosed |
| EP-4108691-A1 | IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | Cornell University (US) | 2022-12-28 | — | — | EP | disclosed |
| EP-3283535-B1 | POLYMERS COMPRISING IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | UNIV CORNELL (US) | 2022-08-10 | — | — | EP | disclosed |
| US-20220127413-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2022-04-28 | — | — | US | disclosed |
| US-20220127413-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2022-04-28 | — | — | US | disclosed |
| US-11242432-B2 | Imidazoles and imidazolium cations with exceptional alkaline stability | CORNELL UNIVERSITY (US) | 2022-02-08 | — | — | US | disclosed |
| US-11242432-B2 | Imidazoles and imidazolium cations with exceptional alkaline stability | CORNELL UNIVERSITY (US) | 2022-02-08 | — | — | US | disclosed |
| CN-108026213-B | Imidazole and imidazolium cations with special base stability | 康奈尔大学 | 2021-11-02 | — | — | CN | disclosed |
| US-20190047963-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2019-02-14 | — | — | US | disclosed |
| US-20190047963-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2019-02-14 | — | — | US | disclosed |
| CN-108026213-A | Imidazoles and glyoxaline cation with special alkaline stability | 康奈尔大学 | 2018-05-11 | — | — | CN | disclosed |
| EP-3283535-A2 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | Cornell University (US) | 2018-02-21 | — | — | EP | disclosed |
| WO-2016168468-A2 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2016-10-20 | — | — | WO | disclosed |
| WO-2016168468-A2 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2016-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127413-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | ALPI, ITPA, ITPR2 | KDM4E 1492/4885NPSR1 3438/4885TSHR 4548/4885 |
| US-20190047963-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | ALPI, ITPA, ITPR2 | KDM4E 1492/4885NPSR1 3438/4885TSHR 4548/4885 |
| US-11242432-B2 | Imidazoles and imidazolium cations with exceptional alkaline stability | ALPI, ITPA, ITPR2 | KDM4E 1492/4885NPSR1 3438/4885TSHR 4548/4885 |
| US-12606666-B2 | Imidazoles and imidazolium cations with exceptional alkaline stability | SCO2, RCC1, SMC2 | KDM4E 1633/4885NPSR1 3925/4885TSHR 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.